Early outcomes after definitive chemoradiation therapy with Vienna/Venezia hybrid high-dose rate brachytherapy applicators for cervical cancer: A single-institution experience.

MLA

Keller, A., et al. “Early Outcomes after Definitive Chemoradiation Therapy with Vienna/Venezia Hybrid High-Dose Rate Brachytherapy Applicators for Cervical Cancer: A Single-Institution Experience.” Brachytherapy, vol. 20, no. 1, Jan. 2021, pp. 104–11. EBSCOhost, https://doi.org/10.1016/j.brachy.2020.08.006.

APA

Keller, A., Rodríguez-López, J. L., Patel, A. K., Vargo, J. A., Kim, H., Houser, C. J., Sukumvanich, P., Berger, J. L., Boisen, M. M., Edwards, R. P., Taylor, S. E., Courtney-Brooks, M. B., Orr, B. C., Olawaiye, A. B., & Beriwal, S. (2021). Early outcomes after definitive chemoradiation therapy with Vienna/Venezia hybrid high-dose rate brachytherapy applicators for cervical cancer: A single-institution experience. Brachytherapy, 20(1), 104–111. https://doi.org/10.1016/j.brachy.2020.08.006

Chicago

Keller, A, J L Rodríguez-López, A K Patel, J A Vargo, H Kim, C J Houser, P Sukumvanich, et al. 2021. “Early Outcomes after Definitive Chemoradiation Therapy with Vienna/Venezia Hybrid High-Dose Rate Brachytherapy Applicators for Cervical Cancer: A Single-Institution Experience.” Brachytherapy 20 (1): 104–11. doi:10.1016/j.brachy.2020.08.006.